Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:

NCT ID: NCT03932617 Completed - Shock Clinical Trials

Correlation Between Changes in End-Tidal Carbon Dioxide and Stroke Volume Variation Detected by Electrical Cardiometry as A Predictor of Fluid Volume Responsiveness in Hemodynamically Unstable Patients in the Intensive Care

Start date: June 1, 2019
Phase:
Study type: Observational

This study will be conducted to assess the role of end-tidal carbon dioxide (PETCO2) monitoring to predict the fluid volume responsiveness in correlation with stroke volume variation detected by electrical cardiometry in patients with hemodynamic instability.

NCT ID: NCT03917446 Completed - Critical Illness Clinical Trials

Volume Responsiveness Assesment After Propofol.

Start date: September 1, 2017
Phase:
Study type: Observational

Patients in ICU who suffer from circulatory insufficiency, regardless the cause that require invasive hemodynamic monitoring. The aim of the study is to correlate stroke volume variation which predicts fluid responsiveness with change of the blood pressure after intravenous admission of propofol. This test could become a surrogate of stroke volume variation in patients with contraindications to minimally invasive hemodynamic monitoring.

NCT ID: NCT03913468 Completed - Septic Shock Clinical Trials

Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.

Start date: January 1, 2019
Phase:
Study type: Observational

This is a retrospective chart review that will measure the impact on outcomes in septic shock patients who were resuscitated with a novel combination of medicines called iHAT (intravenous hydrocortisone -ascorbic acid-thiamine). Septic shock patients treated with this combination of drugs over the past two years will be compared with similar, concurrent septic shock patients who were not treated with this drug given that adoption of this therapy has been variable.

NCT ID: NCT03911817 Completed - Septic Shock Clinical Trials

Impact of Midodrine Administration on the Clinical Outcome of Septic Shock Patients

Start date: November 15, 2017
Phase: Phase 4
Study type: Interventional

1. Assess the impact of midodrine administration on weaning of IV vasopressors 2. Assess the cost effectiveness of using midodrine in critically ill patients

NCT ID: NCT03873675 Completed - Critical Illness Clinical Trials

Parathyroid Hormone Kinetics During CRRT

Start date: May 6, 2019
Phase:
Study type: Observational

The objective of this study is to assess the parathyroid hormone serum concentrations and kinetics in critically ill patients admitted to the intensive care unit due to multi-organ failure and undergoing citrate anticoagulation continuous renal replacement therapy.

NCT ID: NCT03872011 Completed - Septic Shock Clinical Trials

Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock

Start date: February 19, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the combination therapy (vitamin C,thiamine and hydrocortisone) is effective in the treatment of septic shock.

NCT ID: NCT03849625 Completed - Clinical trials for Aspirin-exacerbated Respiratory Disease

Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand

Start date: May 1, 2015
Phase:
Study type: Observational

Study clinical characteristics and phenotypes of patients diagnosed with NSAID sensitivity in Thailand

NCT ID: NCT03844984 Completed - Septic Shock Clinical Trials

Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock Patients

Start date: February 20, 2019
Phase: Phase 3
Study type: Interventional

The aim of the work is to investigate the effect of using lidocaine in combination with low dose ketamine in induction of anesthesia for septic shock patients compared to normal dose of ketamine.

NCT ID: NCT03821714 Completed - Septic Shock Clinical Trials

Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 on Microcirculation in Severe Septic Shock

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This study aimed to investigate the effect of Glucocorticoid combined with vitamin C and vitamin B1 versus hydrocortisone alone on microcirculation in septic shock patients.

NCT ID: NCT03814564 Completed - Circulatory Failure Clinical Trials

ASSESSment of Perfusion, Oxygen Saturation, Endothelial Function and Coagulation in Circulatory SHOCK

ASSESS-SHOCK
Start date: April 1, 2019
Phase:
Study type: Observational

The objective of the observational cohort study is (1) to deduce whether measurements of peripheral near-infrared spectroscopy (NIRS) (lower limb) associate with the development of organ dysfunction as assessed by daily Sequential Orfgan Failure Score (SOFA) in the Intensive Care Unit (ICU), (2)whether cerebral (frontal) tissue haemoglobin oxygen saturation (StO2) values are associated with delirium in the ICU and (3) the association of frontal and peripheral StO2 with other micro- and macrohemodynamic parameters in this patient group , (4) to deduce the associations between shock, endotheliopathy, disseminated intravascular coagulation (DIC) and tissue perfusion and, last, the feasibility of central and peripheral NIRS monitoring in shock patients in the ICU using the Medtronic INVOS NIRS StO2 appliances. In addition, the investigators target to evaluate (5) the incidence, evolution, and outcome of sepsis-associated DIC, and (6) the associations between a) continuous hemodynamic data, b) laboratory data (such as syndecan-1 (SDC-1), vascular adhesion protein 1 (VAP1), CD73, heparin binding protein (HBP), endostatin, chromogranin, mitochondrial function tests,blood count d-dimer, international normalized ratio (INR), neuron specific enolase and metabolomics data) (7) and study associations of singlenucleotide polymorphisms with developing organ dysfunction and 90-day mortality. To compare the hemodynamic alterations of burn patients to septic patients with the intention to find new ways to monitor and manage hemodynamic and particularly microcirculation in burn patients.